The European Medicines Agency (EMA) assesses applications for COVID-19 medicines under the minimum timeframe necessary to allow for a thorough evaluation of the medicine’s benefits and risks. Dedicated guidance and rapid procedures are available…
Europe – COVID-19 guidance: assessment and marketing authorisation
